Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “At Risk of Post-operative Recurrence”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Large-scale testing (Phase 3)Looking for participantsNCT06644937
What this trial is testing

Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhujiang Hospital 30
Not applicableNot Yet RecruitingNCT07042867
What this trial is testing

Prospective Multicenter Cohort Study for the Development and Evaluation of Risk Stratification Tools for Lung Cancers and Their Postoperative Recurrences Using Multimodal Clinical, Radiological, Tissue and Longitudinal Biological Phenotyping Among People at Risk of Lung Cancer

Who this might be right for
Lung Cancer (Diagnosis)
Assistance Publique Hopitaux De Marseille 900
Large-scale testing (Phase 3)WithdrawnNCT01142414
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Study completedNCT00946946
What this trial is testing

Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine

Who this might be right for
Crohn's Disease
Dr. Falk Pharma GmbH 78
Testing effectiveness (Phase 2)Study completedNCT00006051
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
UNICANCER
Testing effectiveness (Phase 2)UnknownNCT04213118
What this trial is testing

Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence

Who this might be right for
Hepatocellular CarcinomaTACEAnlotinib
First Affiliated Hospital Xi'an Jiaotong University 30
Testing effectiveness (Phase 2)UnknownNCT04782804
What this trial is testing

Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Fudan University 30
Large-scale testing (Phase 3)Study completedNCT02770495
What this trial is testing

Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease

Who this might be right for
Crohn Disease
Hospices Civils de Lyon 59
Large-scale testing (Phase 3)Not Yet RecruitingNCT07284394
What this trial is testing

Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in Patients With High Risk of Recurrence of Their Disease

Who this might be right for
Colorectal Adenocarcinoma Metastatic in the LiverColorectal Cancer
UNICANCER 272
Not applicableStudy completedNCT04372147
What this trial is testing

Embolization of the Middle Meningeal Artery for the Prevention of Chronic Subdural Hematoma Recurrence in High Risk Patients (EMPROTECT)

Who this might be right for
Chronic Subdural HematomaAt Risk of Post-operative RecurrenceBurr-hole Surgery
Assistance Publique - Hôpitaux de Paris 342
Testing effectiveness (Phase 2)Ended earlyNCT03945799
What this trial is testing

Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery Recurrence

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT07328828
What this trial is testing

Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence

Who this might be right for
RFS
Second Affiliated Hospital, School of Medicine, Zhejiang University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06762782
What this trial is testing

Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery

Who this might be right for
Hepatocellular Carcinoma (HCC)Adjuvant Therapy in Patients with Hepatocellular Carcinoma (HCC) At High Risk of Recurrence After Curative Resection or Ablation
The First Affiliated Hospital with Nanjing Medical University 276